Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic mice

Abstract Osteoporosis (OP) is characterized by a loss in bone mass and mineral density. The stimulation of the canonical Wnt/β-catenin pathway has been reported to promote bone formation, this pathway is controlled by several regulators as secreted frizzled-related protein-1 (Sfrp-1), antagonist of...

詳細記述

書誌詳細
主要な著者: Patricia García-García, Ricardo Reyes, Daniel García-Sánchez, Flor María Pérez-Campo, José Carlos Rodríguez-Rey, Carmen Évora, Patricia Díaz-Rodríguez, Araceli Delgado
フォーマット: 論文
言語:English
出版事項: BMC 2022-10-01
シリーズ:Journal of Nanobiotechnology
主題:
オンライン・アクセス:https://doi.org/10.1186/s12951-022-01674-5
_version_ 1828317093507891200
author Patricia García-García
Ricardo Reyes
Daniel García-Sánchez
Flor María Pérez-Campo
José Carlos Rodríguez-Rey
Carmen Évora
Patricia Díaz-Rodríguez
Araceli Delgado
author_facet Patricia García-García
Ricardo Reyes
Daniel García-Sánchez
Flor María Pérez-Campo
José Carlos Rodríguez-Rey
Carmen Évora
Patricia Díaz-Rodríguez
Araceli Delgado
author_sort Patricia García-García
collection DOAJ
description Abstract Osteoporosis (OP) is characterized by a loss in bone mass and mineral density. The stimulation of the canonical Wnt/β-catenin pathway has been reported to promote bone formation, this pathway is controlled by several regulators as secreted frizzled-related protein-1 (Sfrp-1), antagonist of the pathway. Thus, Sfrp-1 silencing therapies could be suitable for enhancing bone growth. However, the systemic stimulation of Wnt/β-catenin has been correlated with side effects. This work hypothesizes the administration of lipid-polymer NPs (LPNPs) functionalized with a MSC specific aptamer (Apt) and carrying a SFRP1 silencing GapmeR, could favor bone formation in OP with minimal undesired effects. Suitable SFRP1 GapmeR-loaded Apt-LPNPs (Apt-LPNPs-SFRP1) were administered in osteoporotic mice and their biodistribution, toxicity and bone induction capacity were evaluated. The aptamer functionalization of the NPs modified their biodistribution profile showing a four-fold increase in the bone accumulation and a ten-fold decrease in the hepatic accumulation compared to naked LPNPs. Moreover, the histological evaluation revealed evident changes in bone structure observing a more compact trabecular bone and a cortical bone thickness increase in the Apt-LPNPs-SFRP1 treated mice with no toxic effects. Therefore, these LPNPs showed suitable properties and biodistribution profiles leading to an enhancement on the bone density of osteoporotic mice.
first_indexed 2024-04-13T17:23:19Z
format Article
id doaj.art-9981d1fd9fec4dba8f6f3a8b83d7775f
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-04-13T17:23:19Z
publishDate 2022-10-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-9981d1fd9fec4dba8f6f3a8b83d7775f2022-12-22T02:37:54ZengBMCJournal of Nanobiotechnology1477-31552022-10-0120111910.1186/s12951-022-01674-5Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic micePatricia García-García0Ricardo Reyes1Daniel García-Sánchez2Flor María Pérez-Campo3José Carlos Rodríguez-Rey4Carmen Évora5Patricia Díaz-Rodríguez6Araceli Delgado7Department of Chemical Engineering and Pharmaceutical Technology, Universidad de La LagunaInstitute of Biomedical Technologies (ITB), Universidad de La LagunaDepartment of Molecular Biology, Faculty of Medicine, University of Cantabria-IDIVALDepartment of Molecular Biology, Faculty of Medicine, University of Cantabria-IDIVALDepartment of Molecular Biology, Faculty of Medicine, University of Cantabria-IDIVALDepartment of Chemical Engineering and Pharmaceutical Technology, Universidad de La LagunaInstitute of Biomedical Technologies (ITB), Universidad de La LagunaDepartment of Chemical Engineering and Pharmaceutical Technology, Universidad de La LagunaAbstract Osteoporosis (OP) is characterized by a loss in bone mass and mineral density. The stimulation of the canonical Wnt/β-catenin pathway has been reported to promote bone formation, this pathway is controlled by several regulators as secreted frizzled-related protein-1 (Sfrp-1), antagonist of the pathway. Thus, Sfrp-1 silencing therapies could be suitable for enhancing bone growth. However, the systemic stimulation of Wnt/β-catenin has been correlated with side effects. This work hypothesizes the administration of lipid-polymer NPs (LPNPs) functionalized with a MSC specific aptamer (Apt) and carrying a SFRP1 silencing GapmeR, could favor bone formation in OP with minimal undesired effects. Suitable SFRP1 GapmeR-loaded Apt-LPNPs (Apt-LPNPs-SFRP1) were administered in osteoporotic mice and their biodistribution, toxicity and bone induction capacity were evaluated. The aptamer functionalization of the NPs modified their biodistribution profile showing a four-fold increase in the bone accumulation and a ten-fold decrease in the hepatic accumulation compared to naked LPNPs. Moreover, the histological evaluation revealed evident changes in bone structure observing a more compact trabecular bone and a cortical bone thickness increase in the Apt-LPNPs-SFRP1 treated mice with no toxic effects. Therefore, these LPNPs showed suitable properties and biodistribution profiles leading to an enhancement on the bone density of osteoporotic mice.https://doi.org/10.1186/s12951-022-01674-5Bone regenerationOsteoporosisGene therapyLipid-polymer hybrid nanoparticles
spellingShingle Patricia García-García
Ricardo Reyes
Daniel García-Sánchez
Flor María Pérez-Campo
José Carlos Rodríguez-Rey
Carmen Évora
Patricia Díaz-Rodríguez
Araceli Delgado
Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic mice
Journal of Nanobiotechnology
Bone regeneration
Osteoporosis
Gene therapy
Lipid-polymer hybrid nanoparticles
title Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic mice
title_full Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic mice
title_fullStr Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic mice
title_full_unstemmed Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic mice
title_short Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic mice
title_sort nanoparticle mediated selective sfrp 1 silencing enhances bone density in osteoporotic mice
topic Bone regeneration
Osteoporosis
Gene therapy
Lipid-polymer hybrid nanoparticles
url https://doi.org/10.1186/s12951-022-01674-5
work_keys_str_mv AT patriciagarciagarcia nanoparticlemediatedselectivesfrp1silencingenhancesbonedensityinosteoporoticmice
AT ricardoreyes nanoparticlemediatedselectivesfrp1silencingenhancesbonedensityinosteoporoticmice
AT danielgarciasanchez nanoparticlemediatedselectivesfrp1silencingenhancesbonedensityinosteoporoticmice
AT flormariaperezcampo nanoparticlemediatedselectivesfrp1silencingenhancesbonedensityinosteoporoticmice
AT josecarlosrodriguezrey nanoparticlemediatedselectivesfrp1silencingenhancesbonedensityinosteoporoticmice
AT carmenevora nanoparticlemediatedselectivesfrp1silencingenhancesbonedensityinosteoporoticmice
AT patriciadiazrodriguez nanoparticlemediatedselectivesfrp1silencingenhancesbonedensityinosteoporoticmice
AT aracelidelgado nanoparticlemediatedselectivesfrp1silencingenhancesbonedensityinosteoporoticmice